Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Jakko van Ingen (Lead / Corresponding author), Stefano Aliberti, Claire Andrejak, James D. Chalmers, Luigi R. Codecasa, Charles L. Daley, Naoki Hasegawa, David E. Griffith, Wouter Hoefsloot, Gwen Huitt, Julie Jarand, Byung Woo Jhun, Michael R. Loebinger, Theodore K. Marras, Kozo Morimoto, Eva Polverino, Felix C. Ringshausen, Miguel Santin, Rachel Thomson, Dirk WagnerRichard J. Wallace, Kevin L. Winthrop, Jae-Joon Yim

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
35 Downloads (Pure)


Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.

Original languageEnglish
Pages (from-to)e256-e259
Number of pages4
JournalClinical Infectious Diseases
Issue number1
Early online date10 Sept 2020
Publication statusPublished - 1 Jul 2021


  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Lung Diseases/chemically induced
  • Mycobacterium Infections, Nontuberculous
  • Mycobacterium avium Complex
  • Mycobacterium avium-intracellulare Infection/drug therapy
  • Nontuberculous Mycobacteria
  • Mycobacterium avium complex
  • antibiotic treatment
  • nontuberculous mycobacteria
  • azithromycin
  • adverse events

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey'. Together they form a unique fingerprint.

Cite this